Adagrasib in Non-Small-Cell Lung Cancer

Dr. Kotecha reports receiving honoraria from Accuray, Elekta, ViewRay, Novocure, Elsevier, and Brainlab and institutional research funding from Medtronic, Blue Earth Diagnostics, Novocure, GT Medical Technologies, AstraZeneca, Exelixis, ViewRay, and Brainlab. Dr. Sahgal reports receiving consulting fees from AbbVie, Merck, Roche, Varian (Medical Advisory Group), Elekta, Brainlab, and VieCure (for serving on the medical advisory board); fees for being an ex officio board member of the International Stereotactic Radiosurgery Society; honoraria for educational seminars from Elekta, Accuray, Varian (for serving on the central nervous system teaching faculty), Brainlab, and Medtronic Kyphon; a research grant from Elekta; travel fees from Elekta, Varian, and Brainlab; and fees for belonging to the Elekta MR Linac Research Consortium, the Elekta Spine Radiosurgery Research Consortium, and the Elekta Spine, Oligometastases, and Linac Based SRS Consortia. Dr. Mehta reports receiving consulting fees from Karyopharm, Sapience, Zap Surgical Systems, Mevion Medical Systems, Xoft, and BOD Oncoceutics and holding stock in Chimerix. No other potential conflict of interest relevant to this letter was reported.